EcoDrugPlus

Integrin, Beta 1b

Ensembl ID : ENSELUG00000007513
Gene Symbol: ITGB1B
1 Cross references
230 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSELUG00000009419
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2

Ensembl ID : ENSELUG00000010997
Gene Symbol: LOC105027406
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSELUG00000005492
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSELUG00000017764
Gene Symbol: IDH2
3 Cross references
185 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2, Mitochondrial

Ensembl ID : ENSELUG00000019359
Gene Symbol: IDH2
2 Cross references
163 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSELUG00000023382
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSELUG00000004401
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSELUG00000005218
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSELUG00000011732
Gene Symbol: KIF5B
4 Cross references
276 Possible Orthologues:

Kinesin-1 Heavy Chain

Ensembl ID : ENSELUG00000004374
Gene Symbol: LOC105019408
3 Cross references
276 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSELUG00000020355
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).